Cite

HARVARD Citation

    Oh, J. et al. (2021). Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies. Journal of central nervous system disease. p. . [Online]. 
  
Back to record